Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Novo Nordisk Stock Sank on Tuesday
Why Novo Nordisk Stock Sank on Tuesday
Why Novo Nordisk Stock Sank on Tuesday
Submitted by
admin
on July 11, 2023 - 11:23pm
Source:
Motley Fool
News Tags:
Novo Nordisk
obesity
Wegovy
Headline:
Why Novo Nordisk Stock Sank on Tuesday
snippet:
A media report detailed the lack of staying power of weight loss drugs.
Novo Nordisk has gained fame and popularity as the developer of one of those, Wegovy.
Do Not Allow Advertisers to Use My Personal information